Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway

Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway
Title:
Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway
Other Titles:
Cell Research
Keywords:
Publication Date:
05 June 2015
Citation:
Cell Research (2015) 25:801–817. doi:10.1038/cr.2015.69;
Abstract:
The tumor suppressor Merlin/NF2 functions upstream of the core Hippo pathway kinases Lats1/2 and Mst1/2, as well as the nuclear E3 ubiquitin ligase CRL4DCAF1. Numerous mutations of Merlin have been identified in Neurofibromatosis type 2 and other cancer patients. Despite more than two decades of research, the upstream regulator of Merlin in the Hippo pathway remains unknown. Here we show by high-resolution crystal structures that the Lats1/2-binding site on the Merlin FERM domain is physically blocked by Merlin's auto-inhibitory tail. Angiomotin binding releases the auto-inhibition and promotes Merlin's binding to Lats1/2. Phosphorylation of Ser518 outside the Merlin's auto-inhibitory tail does not obviously alter Merlin's conformation, but instead prevents angiomotin from binding and thus inhibits Hippo pathway kinase activation. Cancer-causing mutations clustered in the angiomotin-binding domain impair angiomotin-mediated Merlin activation. Our findings reveal that angiomotin and Merlin respectively interface cortical actin filaments and core kinases in Hippo signaling, and allow construction of a complete Hippo signaling pathway.
License type:
http://creativecommons.org/licenses/by-nc-nd/4.0/
Funding Info:
Description:
Full paper can be downloaded from the Publisher's URL provided.
ISSN:
1001-0602
1748-7838
Files uploaded:
File Size Format Action
There are no attached files.